stooocks.com

Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.

Samsung C&T Corporation

South Korea · KRX: 028260.KS · Market cap: $34.8B · P/E: 16.7 · P/S: 1.1

Samsung C&T is a South Korean conglomerate that builds major construction projects, trades goods around the world, and runs fashion, resort, catering, food distribution, and bio businesses.

Samsung C&T is a South Korean company that wears several hats at once. It builds big things — skyscrapers, power plants, roads, and chemical plants — through its construction and engineering arm. It also runs a global trading business that buys and sells raw materials and industrial goods across borders. And it operates a collection of consumer businesses: fashion brands, the Everland resort and theme park, catering and food distribution, and a bio services unit that manufactures biopharmaceutical products for other drug companies.

Samsung C&T Corporation (028260.KS) Semiconductor fabrication plant construction: line art illustration of Construction crew in hard hats beside a steel-framed chip fab building with tower crane
Chip plant construction
It builds the huge factories where semiconductor chips are made.

The construction business is the heart of the company. Samsung C&T has built some of the world's most famous tall buildings, including the Burj Khalifa in Dubai and the Petronas Towers in Malaysia. It handles everything from design and engineering to actually pouring concrete and managing a site. Customers are governments, developers, and industrial firms who hire Samsung C&T because the projects are enormous and risky, and few firms have the track record to pull them off. The trading arm is the classic Korean general trading company model: Samsung C&T sources and moves commodities and equipment, connecting sellers and buyers across countries. It earns a margin on these deals and sometimes invests in the resources it trades. The fashion, resort, and food businesses are smaller but give the company steady consumer revenue and brand recognition in Korea. The bio services unit, Samsung Biologics, has become a notable contract manufacturer for global drug companies — making biologic medicines on behalf of firms that don't want to build their own factories. What makes Samsung C&T unusual is the mix: a hard-hat engineering firm, a global commodities middleman, and a collection of lifestyle brands under one roof. That diversification helps smooth the bumps. When construction slows, trading or bio manufacturing can pick up the slack. The main risks are the things that hit any big builder — project delays, cost overruns, and swings in global demand for infrastructure and raw materials.


The company is part of the wider Samsung group, and its shares trade on the Korea Stock Exchange. It pays dividends and has used its cash to invest in its bio business and other growth areas. For most investors, Samsung C&T is a way to own a slice of Korean engineering and global trade, with a bit of theme-park fun and fashion on the side.

Saved answer · last researched 12 Nov 2026